82 results
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent
424B5
HEPA
Hepion Pharmaceuticals Inc
2 Oct 23
Prospectus supplement for primary offering
4:52pm
supplement or free writing prospectus prepared by or on behalf of us or to which we may have referred you. We take no responsibility for, and can provide … issue of warrants. A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant
8-K
02tt8eqt
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-1.1
503qiqden
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
424B5
8u065h5iuljwqo0nej3
21 Jul 23
Prospectus supplement for primary offering
4:39pm
8-K
EX-10.3
uor3v5o vjup0
8 Nov 22
Hepion Pharmaceuticals Announces Pricing of $20.0 Million Private Placement of Convertible Redeemable Preferred Stock
8:41pm
8-K
EX-99.1
5jho6rbt
28 Jun 22
Departure of Directors or Certain Officers
9:46am